Farmatsevtychnyi zhurnal,
Год журнала:
2024,
Номер
6, С. 73 - 83
Опубликована: Дек. 27, 2024
Possible
way
to
improve
the
control
of
multidrug-resistant
epilepsy
can
be
considered
use
drugs
from
other
pharmacological
groups
as
an
adjunct
classical
antiepileptic
(AEDs).
One
promising
such
medicines
is
anti-inflammatory
drug
with
a
unique
mechanism
action
–
dual
COX-2/5-LOG
inhibitor
darbufelone,
for
which
per
se
pronounced
anticonvulsant
effect
was
previously
established.
The
aim
work
study
darbufelone
on
potential
drugs:
sodium
valproate
and
carbamazepine.
conducted
using
64
albino
mice.
Acute
seizures
were
modeled
by
single
injection
GABAA
receptor
antagonist
pentylenetetrazole.
Classical
AEDs
administered
intragastrically
at
ED50
½
30
min
before
pentylenetetrazole:
doses
300
150
mg/kg,
respectively,
carbamazepine
100
50
respectively;
determined
effective
dose
mg/kg.
Pentylenetetrazole
80
mg/kg
subcutaneously.
It
found
that
combination
provided
protective
pentylenetetrazole-induced
seizure
model,
verified
prolongation
latency
period
first
seizures,
decrease
in
number
severity
seizures.
In
addition,
also
protection
mice
death
level
conditionally
dose,
significantly
exceeded
effectiveness
monotherapy
se.
Darbufelone
positively
modulated
ED50,
not
only
reducing
lethality
(at
dose),
but
protecting
severe
tonic
paroxysms,
prolonging
life
span
animals.
Thus,
model
acute
it
established
has
its
own
properties
able
enhance
their
subeffective
doses.
results
obtained
provide
grounds
consider
adjuvant
provides
under
conditions
experimental
equivalent
refractory
epilepsy.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(12), С. 6488 - 6488
Опубликована: Июнь 12, 2024
A
central
role
for
neuroinflammation
in
epileptogenesis
has
recently
been
suggested
by
several
investigations.
This
systematic
review
explores
the
of
inflammatory
mediators
epileptogenesis,
its
association
with
seizure
severity,
and
correlation
drug-resistant
epilepsy
(DRE).
The
study
analysed
articles
published
JCR
journals
from
2019
to
2024.
search
strategy
comprised
MESH,
free
terms
“Neuroinflammation”,
selective
searches
following
single
biomarkers
that
had
previously
selected
relevant
literature:
“High
mobility
group
box
1/HMGB1”,
“Toll-Like-Receptor
4/TLR-4”,
“Interleukin-1/IL-1”,
“Interleukin-6/IL-6”,
“Transforming
growth
factor
beta/TGF-β”,
“Tumour
necrosis
factor-alpha/TNF-α”.
These
queries
were
all
combined
MESH
“Epileptogenesis”
“Epilepsy”.
We
found
243
related
neuroinflammation,
356
biomarker
type.
After
eliminating
duplicates,
324
evaluated,
272
excluded
55
evaluated
authors.
total
21
included
qualitative
evaluation,
including
18
case–control
studies,
2
case
series,
1
prospective
study.
As
conclusion,
this
provides
acceptable
support
five
biomarkers,
TNF-α
some
soluble
receptors
(sTNFr2),
HMGB1,
TLR-4,
CCL2
IL-33.
Certain
receptors,
cytokines,
chemokines
are
examples
neuroinflammation-related
may
be
crucial
early
diagnosis
refractory
or
connected
control
epileptic
seizures.
Their
value
will
better
defined
future
studies.
Molecular Neurobiology,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 14, 2024
Abstract
Neural
circuits
consisting
of
neurons
and
glial
cells
help
to
establish
all
functions
the
CNS.
Microglia,
resident
immunocytes
CNS,
are
endowed
with
UDP-sensitive
P2Y6
receptors
(P2Y6Rs)
which
regulate
phagocytosis/pruning
excessive
synapses
during
individual
development
refine
in
an
activity-dependent
manner
adulthood.
In
addition,
this
type
receptor
plays
a
decisive
role
primary
(Alzheimer’s
disease,
Parkinson’s
neuropathic
pain)
secondary
(epilepsy,
ischemic-,
mechanical-,
or
irradiation-induced)
neurodegeneration.
A
whole
range
microglial
cytokines
controlled
by
P2Y6Rs,
such
as
interleukins
IL-1β,
IL-6,
IL-8,
tumor
necrosis
factor-α
(TNF-α),
leads
neuroinflammation,
resulting
Hence,
small
molecular
antagonists
P2Y6Rs
genetic
knockdown
provide
feasible
ways
alleviate
inflammation-induced
neurological
disorders
but
might
also
interfere
regulation
synaptic
circuitry.
The
present
review
aims
at
investigating
dual
microglia,
both
shaping
neural
targeted
phagocytosis
promoting
neurodegenerative
illnesses
fostering
neuroinflammation
through
multiple
transduction
mechanisms.
Ethnopharmacological
relevance:
Pterocarpus
mildbraedii
was
believed
to
have
multiple
benefits,
including
antioxidant,
antipyretic,
antalgic,
anti-convulsant,
and
anxiolytic
effects.
Previous
studies
reported
that
water
extract
(Pm)
contained
secondary
metabolites
able
cross
the
BBB.
However,
Pm's
systemic
mechanism
targets
for
neuroinflammation
remain
largely
unexplored.Aim
of
study:
This
research
used
a
systems
pharmacology
approach
experiment
evaluation
reveal
potential
protective
effects
Pm
against
neuroinflammation,
oxidative
stress,
behavioral
changes
in
an
LPS-induced
Alzheimer's
disease
(AD)
rat
model.Materials
methods:
integrated
network
analysis
experimental
verification
evaluate
pharmacological
PM
AD
systematically.
Swiss
Target
Prediction,
GeneCards,
STRING
databases
were
employed
identify
targets.
The
interaction
between
active
components
hub
confirmed
via
molecular
docking.
GO
KEGG
pathway
analyses
also
carried
out.
Further,
vitro
bioassays
explore
anti-inflammatory
antioxidant
activities
and,
finally,
vivo
neuroinflammatory
stress
markers.Results:
Network
docking
revealed
primarily
regulates
signaling
pathways
such
as
ESR1,
ESR2,
BACE1,
MAPK1,
TLR4,
IL6,
GSK3B
through
like
liquiritigenin
pterocarptriol.
identified
significant
action
AD,
nitrogen
metabolism
VEGF
pathway.
In
vitro,
demonstrated
their
properties,
along
with
inhibitory
on
AchE
BchE.
Behavioral
tests
showed
LPS
exposure
impaired
exploratory
behavior,
spatial
learning,
increased
anxiety
rats,
correlating
brain,
marked
by
elevated
MDA
NO
levels,
decreased
CAT,
SOD,
GSH
levels.
raised
TNF-α
IL-6
levels
while
reducing
dopamine,
serotonin,
AChE
activity.
Notably,
treatment
significantly
mitigated
improved
activity,
restored
neurotransmitter
animals.Conclusion:
paper
established
P.
could
inhibit
its
components,
targets,
pathways.
milbraedii
may
be
candidate
treatment.
CNS Neuroscience & Therapeutics,
Год журнала:
2025,
Номер
31(1)
Опубликована: Янв. 1, 2025
ABSTRACT
Background
Epilepsy
has
a
genetic
predisposition,
yet
causal
factors
and
the
dynamics
of
immune
environment
in
epilepsy
are
not
fully
understood.
Methods
We
analyzed
peripheral
blood
samples
from
patients,
identifying
key
genes
associated
with
risk
through
Mendelian
randomization,
using
eQTLGen
genome‐wide
association
studies.
The
environment's
composition
was
explored
CIBERSORT.
An
mouse
model
established
to
validated
expression
at
transcriptomic
proteomic
levels
single‐cell
analysis.
Relevant
pathways
were
verified.
Finally,
we
developed
predictive
for
antiepileptic
drug
response
patients.
Results
found
that
CDC25B
,
DNMT1
GZMA
MTX1
SSH2
decreases
risk,
whereas
FGD3
RAF1
SH3BP5L
increase
it.
patients
exhibited
an
altered
profile,
notably
increased
activated
mast
cells
decreased
CD4
memory
T
γδ
cells.
Eight
significantly
related
this
environment.
In
animal
model,
upregulated
both
mRNA
protein
hippocampus.
specifically
elevated
microglia
primarily
actin
regulation.
trained
deployed
on
online
platform.
Conclusions
This
study
elucidates
linked
epilepsy,
delineates
landscape,
highlights
interaction
between
these
domains,
providing
insights
into
potential
mechanisms
treatments.
Epilepsy
is
a
chronic
neurological
disorder
marked
by
recurrent
seizures,
significantly
impacting
individuals
worldwide.
Current
treatments
are
often
ineffective
for
third
of
patients
and
can
cause
severe
side
effects,
necessitating
new
therapeutic
approaches.
Glial
cells,
particularly
astrocytes,
microglia,
oligodendrocytes,
emerging
as
crucial
targets
in
epilepsy
management.
Astrocytes
regulate
neuronal
homeostasis,
excitability,
synaptic
plasticity,
playing
key
roles
maintaining
the
blood-brain
barrier
(BBB)
mediating
neuroinflammatory
responses.
Dysregulated
astrocyte
functions,
such
reactive
astrogliosis,
lead
to
abnormal
activity
seizure
generation.
They
release
gliotransmitters,
cytokines,
chemokines
that
may
exacerbate
or
mitigate
seizures.
Microglia,
innate
immune
cells
CNS,
contribute
neuroinflammation,
glutamate
excitotoxicity,
balance
between
excitatory
inhibitory
neurotransmission,
underscoring
their
dual
role
promotion
protection.
Meanwhile,
primarily
involved
myelination,
also
modulate
axonal
excitability
neuron-glia
network
underlying
pathogenesis.
Understanding
dynamic
interactions
glial
with
neurons
provides
promising
avenues
novel
therapies.
Targeting
these
improved
control
better
clinical
outcomes,
offering
hope
refractory
epilepsy.
Pediatric
epilepsy
presents
challenges
in
treatment
optimization,
with
a
significant
proportion
of
patients
experiencing
inadequate
seizure
control
despite
anti-seizure
medications
(ASMs)
therapy.
Recent
research
has
indicated
the
involvement
neuroinflammation
and
immune-mediated
mechanisms
pathogenesis,
suggesting
potential
interplay
between
immunological
factors
ASMs
responsiveness.
This
study
aimed
to
investigate
role
pediatric
generalized,
focal
their
interaction
understand
influence
on
outcomes.
A
retrospective
cohort
was
conducted
involving
136
patients,
categorized
into
Anti-seizure
Insensitive
Group
(n
=
67)
Sensitive
69).
Immunoglobulin
levels
factors,
including
cytokines,
were
assessed
before
treatment.
Seizure
characteristics
also
analyzed.
Associations
characteristics,
sensitivity
evaluated.
The
revealed
differences
interleukin-6
(IL-6),
IL-1β
IL-10
levels,
insensitive
sensitive
groups.
Furthermore,
frequency,
drug-resistant
seizures,
severity,
seizure-free
period,
status
epilepticus
all
demonstrated
correlations
ASMs,
negative
for
positive
period
epilepticus.
highlights
complex
immune
function,
mechanisms,
underscoring
need
comprehensive
understanding
modulation
drug
response
epilepsy.
Not
applicable.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(7), С. 2831 - 2831
Опубликована: Март 21, 2025
Chemokine
(CXC
motif)
ligand
8
(CXCL8)
is
a
pro-inflammatory
chemokine
binding
to
CXC
motif
receptors
1/2
(CXCR1/2).
Patients
with
temporal
lobe
epilepsy
(TLE)
exhibit
increased
serum
CXCL8
levels.
1
(CXCL1),
murine
ortholog
of
CXCL8,
has
been
implicated
in
seizure
generation
and
neuronal
loss.
This
study
evaluated
the
antiepileptogenic
antiseizure
effects
reparixin
amygdaloid
kindling
rat
model
TLE.
Reparixin
was
administered
during
period
for
14
days,
seizures
were
induced
twice
daily
via
electrical
stimulation.
To
assess
effects,
fully
kindled
animals,
stimulations
performed
24
48
h
later.
Levetiracetam,
broad-spectrum
drug,
intraperitoneally
(i.p.)
as
positive
control
before
each
delayed
secondary
generalization
kindling.
reduced
severity
after-discharge
duration
animals
at
from
treatment
initiation.
CXCR1/2
protein
kinase
B
pathway
proteins
exhibited
no
significant
changes;
phospho-extracellular
signal-regulated
(pERK)/ERK
ratio
cortex
hippocampus.
CXCL1
expression
significantly
decreased
cortex.
partial
by
modulating
CXCL1–CXCR1/2
axis
reducing
ERK
signaling.
Already
clinical
trials
on
respiratory
diseases,
could
be
repurposed
therapy.
Frontiers in Neuroscience,
Год журнала:
2025,
Номер
19
Опубликована: Март 27, 2025
Epilepsy
is
the
second
most
common
neurological
disorder
and
affects
approximately
50
million
people
worldwide.
Despite
advances
in
antiepileptic
therapy,
about
30%
of
patients
develop
refractory
epilepsy.
Recent
studies
have
shown
sleep,
glymphatic
function,
cerebral
small
vessel
disease
(CSVD),
epilepsy
are
interrelated
by
sharing
a
multidirectional
relationship
influencing
their
severity
progression.
Sleep
plays
vital
role
brain
homeostasis
promotes
clearance
responsible
for
removal
metabolic
wastes
neurotoxic
substances
from
brain.
Disrupted
sleep
feature
can
lead
to
impairment
efficiency
or
glymphopathy,
promoting
neuroinflammation
accrual
epileptogenic
factors.
CSVD,
occurring
up
60%
aging
population,
further
exacerbates
neurovascular
compromise
neurodegeneration
increasing
seizure
susceptibility
worsening
outcomes.
This
narrative
review
aims
discuss
molecular
pathophysiological
inter-relationships
between
these
factors,
providing
new
framework
that
places
glymphopathy
CSVD
as
contributors
epileptogenesis
conditions
disruption.
We
propose
an
integrative
model
wherein
vascular
insufficiency
interact
positive
feedback
loop
disruption
increased
vulnerability
mediated
epileptic
activity.
Acknowledging
interactions
has
significant
impacts
on
both
research
clinical
practice.
Targeting
modulation,
cerebrovascular
health
presents
promising
avenue
therapeutic
intervention.
Future
should
focus
developing
precision
medicine
approaches
integrate
neuro-glial-vascular
mechanisms
optimize
management.
Clinically,
addressing
disturbances
may
improve
treatment
effectiveness,
reduce
burden,
overall
highlights
need
interdisciplinary
break
vicious
cycle
epilepsy,
disturbance,
pathology,
paving
way
innovative
paradigms.